HCA Healthcare (HCA)
(Delayed Data from NYSE)
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 6:12 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 6:12 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
HCA Healthcare (HCA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $172.58, marking a -1.42% move from the previous day.
Here's Why You Should Retain McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Acadia Healthcare (ACHC) JV to Build Behavioral Health Hospital
by Zacks Equity Research
Acadia Healthcare (ACHC) enters into a JV with Massachusetts-based Tufts Medicine to construct a behavioral health hospital and address the dire need for better behavioral healthcare services across Boston.
Stock Market News for Jul 1, 2022
by Zacks Equity Research
U.S. stocks ended lower on Thursday, with the S&P recording its worst first-half performance in more than 50 years.
HCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JV
by Zacks Equity Research
HCA Healthcare (HCA) inks a joint venture with McKesson to strengthen the cancer offerings suite of both partners. The move will offer HCA the chance to capitalize on the growing cancer therapeutics market.
HCA Healthcare (HCA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $179.82 in the latest trading session, marking a -1.38% move from the prior day.
McKesson's (MCK) Latest JV to Boost Cancer Treatment Options
by Zacks Equity Research
McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.
HCA Healthcare (HCA) Scraps Utah Buyout Post FTC's Roadblock
by Zacks Equity Research
HCA Healthcare's (HCA) aborted acquisition follows another abandoned buyout plan involving RWJBarnabas Health and Saint Peter's Healthcare System.
HCA Healthcare (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $173.10, moving +0.9% from the previous trading session.
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $181.69, marking a +1.34% move from the previous day.
Select Medical (SEM) Inks JV to Serve Venice and Nearby Areas
by Zacks Equity Research
Select Medical (SEM) teams up with Community Health's arm, ShorePoint Health Venice, for jointly operating a hospital dedicated to serve post-acute care needs of patients.
HCA Healthcare's (HCA) Galen College Adds 8th New Facility
by Zacks Equity Research
HCA Healthcare's (HCA) Galen College nursing campus addition comes when the country is suffering from a nursing shortage.
HCA Healthcare (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $207.52, marking a +1.32% move from the previous day.
HCA Healthcare's (HCA) Utah Acquisition Faces Fed Roadblocks
by Zacks Equity Research
The trade watchdog expects HCA Healthcare's (HCA) Utah acquisition to induce market concentration and eliminate Steward Health Care as a low-cost competitor.
HCA Healthcare (HCA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $206.95, moving -1.64% from the previous trading session.
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $206.16, moving +0.68% from the previous trading session.
Encompass Health (EHC) Unveils Plan to Better Serve Texas
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.
Zacks Earnings Trends Highlights: Netflix, General Electric, and HCA Holdings
by Zacks Equity Research
Netflix, General Electric, and HCA Holdings are part of Zacks Earnings Trends article.
Breaking Down the First Quarter Earnings Season So Far
by Sheraz Mian
Excluding the -16.3% decline in Finance sector earnings, Q1 earnings for the rest of the index members that have reported would be up +15.4%.
Breaking Down the First Quarter Earnings Season So Far
by Sheraz Mian
Excluding the -16.3% decline in Finance sector earnings, Q1 earnings for the rest of the index members that have reported would be up +15.4%.
Zacks Earnings Trends Highlights: Netflix, General Electric and HCA Holdings
by Zacks Equity Research
Netflix, General Electric and HCA Holdings have been highlighted in this Earnings Trends article.
Earnings Estimates Come Under Pressure Outside of Energy
by Sheraz Mian
Looking at Q1 as a whole, total S&P 500 earnings are expected to be up +6.6% on +11.1% higher revenues. This is a significant deceleration from what we have been seeing in the preceding quarters...
Earnings Estimates Come Under Pressure Outside of Energy
by Sheraz Mian
Looking at Q1 as a whole, total S&P 500 earnings are expected to be up +6.6% on +11.1% higher revenues. This is a significant deceleration from what we have been seeing in the preceding quarters...
Company News for Apr 25, 2022
by Zacks Equity Research
Companies in The News Are: SLB,HCA,KMB,NEM
HCA Healthcare (HCA) Q1 Earnings Miss, Trims '22 EPS View
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results reflect elevated expenses related to salaries and benefits, partly offset by an uptick in revenues driven by higher patient admissions.